Misplaced Pages

Butyrylnorfentanyl

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Synthetic opioid analgesic metabolite

This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (August 2023)

Pharmaceutical compound
Butyrylnorfentanyl
Identifiers
IUPAC name
  • N-phenyl-N-4-piperidinyl-butanamide,
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC15H22N2O
Molar mass246.354 g·mol
3D model (JSmol)
SMILES
  • O=C(N(C1=CC=CC=C1)C2CCNCC2)CCC
InChI
  • InChI=1S/C15H22N2O.ClH/c1-2-6-15(18)17(13-7-4-3-5-8-13)14-9-11-16-12-10-14;/h3-5,7-8,14,16H,2,6,9-12H2,1H3;1H
  • Key:VVVKOVYWEOKXGV-UHFFFAOYSA-N

Butyrnorfentanyl or butyrylnorfentanyl is an inactive synthetic opioid analgesic drug precursor. It is an analog of fentanyl.

See also

References

  1. Strayer KE (2018). "LC-MS/MS-based method for the multiplex detection of 24 fentanyl analogues and metabolites in whole blood at sub ng mL–1 concentrations". ACS Omega. 3 (1): 514–523. doi:10.1021/acsomega.7b01536. PMC 5793031. PMID 29399650.
  2. Mannocchi G (2020). "Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases". Analytical and Bioanalytical Chemistry. 412 (21): 5125–5145. doi:10.1007/s00216-020-02462-6. hdl:11573/1477635. PMID 32062830. S2CID 211128392.
  3. Freni F (2020). "Determination of fentanyl and 19 derivatives in hair: application to an Italian population". Journal of Pharmaceutical and Biomedical Analysis. 189: 113476. doi:10.1016/j.jpba.2020.113476. PMID 32693203. S2CID 220699407.
  4. Lanzarotta A (2020). "Identification of opioids and related substances using handheld Raman spectrometers". Journal of Forensic Sciences. 65 (2): 421–427. doi:10.1111/1556-4029.14217. PMID 31643087. S2CID 204849539.
  5. Larabi IA (2020). "Development and validation of liquid chromatography-tandem mass spectrometry targeted screening of 16 fentanyl analogs and U-47700 in hair: Application to 137 authentic samples". Drug Testing and Analysis. 12 (9): 1298–1308. doi:10.1002/dta.2868. PMID 32476263. S2CID 219172113.
  6. Strayer KE (2018). "A LC-MS/MS-Based Method for the Multiplex Detection of 24 Fentanyl Analogs and Metabolites in Whole Blood at Sub ng mL-1 Concentrations". {{cite journal}}: Cite journal requires |journal= (help)
  7. Vaiano F (2021). "Development of a new LC-MS/MS screening method for detection of 120 NPS and 43 drugs in blood". Separations. 8 (11): 221. doi:10.3390/separations8110221. hdl:2158/1251026.
  8. Kern S. "Rapid-field-deployable DART-MS screening technique for 87 opioids and drugs of abuse, including fentanyl and fentanyl analogs". Journal of Regulatory Science. 10 (2).
  9. Garneau B (2021). "A comprehensive analytical process, from NPS threat identification to systematic screening: method validation and one-year prevalence study". Forensic Science International. 318: 110595. doi:10.1016/j.forsciint.2020.110595. PMID 33279767. S2CID 227521467.
  10. Carelli C (2022). "Old and New Synthetic and Semi-synthetic Opioids Analysis in Hair: A Review". Talanta Open. 100108.

Further reading

  • Higashikawa Y, Suzuki S (June 2008). "Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues". Forensic Toxicology. 26 (1): 1–5. doi:10.1007/s11419-007-0039-1. S2CID 22092512.
  • Alburges ME, Hanson GR, Gibb JW, Sakashita CO, Rollins DE (1992). "Fentanyl receptor assay. II. Utilization of a radioreceptor assay for the analysis of fentanyl analogs in urine". J Anal Toxicol. 16 (1): 36–41. doi:10.1093/jat/16.1.36. PMID 1322477.
  • Woods J, Medzihradsky F, Smith C, Winger G, Gmerek D (1988). "Evaluation of new compounds for opioid activity: 1987 annual report". NIDA Res. Monogr. 81: 543–90. PMID 3136388.
  • Aceto M, Bowman E, Harris L, May E (1988). "Dependence studies of new compounds in the rhesus monkey, rat, and mouse, 1987". NIDA Res. Monogr. 81: 485–542. PMID 3136386.
  • Brine GA, Boldt KG, Huang PT, Sawyer DK, Carroll FI (2009). "Carbon-13 nuclear magnetic resonance spectra of fentanyl analogs". Journal of Heterocyclic Chemistry. 26 (3): 677–686. doi:10.1002/jhet.5570260329.
Analgesics (N02A, N02B)
Opioids
Opiates/opium
Semisynthetic
Synthetic
Paracetamol-type
NSAIDs
Propionates
Oxicams
Acetates
COX-2 inhibitors
Fenamates
Salicylates
Pyrazolones
Others
Cannabinoids
Ion channel
modulators
Calcium blockers
Sodium blockers
Potassium openers
Myorelaxants
Others
General anesthetics (N01A)
Inhalational
Injection
Phenols
Barbiturates
Benzodiazepines
Opioids
Arylcyclohexylamines
Neuroactive steroids
Others
Opioid receptor modulators
μ-opioid
(MOR)
Agonists
(abridged;
full list)
Antagonists
δ-opioid
(DOR)
Agonists
Antagonists
κ-opioid
(KOR)
Agonists
Antagonists
Nociceptin
(NOP)
Agonists
Antagonists
Others
  • Others: Kyotorphin (met-enkephalin releaser/degradation stabilizer)
Categories: